Finally, we investigated whether raloxifene—a selective estrogen receptor modulator—may be a potential treatment for insomnia in postmenopausal women with schizophrenia, as it has been extensively explored to treat psychopathological symptoms. Here, ESR1 is linked to insomnia measurement.